Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
AstraZeneca
McKesson
Teva
Queensland Health
Federal Trade Commission
Deloitte
Cantor Fitzgerald
Chubb

Generated: August 19, 2018

DrugPatentWatch Database Preview

Hikma Company Profile

« Back to Dashboard

What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?

HIKMA has one hundred and fifty-seven approved drugs.

There are five US patents protecting HIKMA drugs. There are two tentative approvals on HIKMA drugs.

Drugs and US Patents for Hikma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms HYDROCORTISONE hydrocortisone TABLET;ORAL 083365-002 Feb 23, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Pharms GLIMEPIRIDE glimepiride TABLET;ORAL 078952-001 Aug 1, 2013 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Intl Pharms ISOSORBIDE DINITRATE isosorbide dinitrate TABLET;ORAL 040591-001 Jan 10, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Pharms OLANZAPINE olanzapine TABLET;ORAL 204866-001 Jun 16, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for HIKMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 0.6 mg ➤ Subscribe 2016-06-10
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
Queensland Health
Citi
Fuji
Accenture
Baxter
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.